Global Drug Discovery: Europe Is Ahead-Reference-Cited by-同舟云学术

Global Drug Discovery: Europe Is Ahead

Published:2009-01 Issue:Supplement 1 Volume:28 Page:w969-w977
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Light Donald W.¹

Affiliation:

1. Donald Light () is the Lorry Lokey Visiting Professor at Stanford University, in Stanford, California, and a professor of social medicine in the Department of Psychiatry at the University of Medicine and Dentistry of New Jersey.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference28 articles.

1. High Level Group on Innovation and Provision of Medicines in the European Union, “Recommendations for Action” (Brussels: European Commission—Enterprise and Industry, 2002).

2. The Quantity And Quality Of Worldwide New Drug Introductions, 1982–2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access;PLOS ONE;2022-09-06

2. News coverage of drug development: implications for the conveyance of health information;BMC Public Health;2021-10-07

3. Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry;International Journal of Political Economy;2018-10-02

4. Trump blames free riding foreign states for high US drug prices;BMJ;2018-03-16

5. The opportunity cost of pharmaceutical price increases: improving health by investing in education;Critical Public Health;2018-03-06